E
OFIX icon

Ergoteles’s Orthofix Medical OFIX Stock Holding History

Ergoteles’s Portfolio OFIX Stock Details OFIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-52,546
Closed -$1.08M – 1618
2022
Q4 		$1.08M Buy
52,546
+36,580
+229% +$645K 0.04% 443
2022
Q3 		$305K Buy
15,966
+6,538
+69% +$147K 0.01% 966
2022
Q2 		$222K Buy
+9,428
New +$270K 0.01% 1268
2022
Q1 		– Sell
-11,000
Closed -$342K – 1523
2021
Q4 		$342K Buy
+11,000
New +$368K 0.01% 804

Other funds holding OFIX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $8.43B AUM 52.02% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Ergoteles's OFIX Position: Q1 2023 in Review

Ergoteles sold out of Orthofix Medical (OFIX) in Q1 2023, closing a stake of 52,546 shares — an estimated $1.08M sold.

Ergoteles first reported a position in OFIX in Q4 2021 and held it in 4 quarters. The position peaked at $1.08M in Q4 2022. 162 funds tracked by Wall St. Rank hold OFIX as of Q1 2023.

  • Ergoteles reported no remaining Orthofix Medical position as of Q1 2023 after selling out during the quarter.
  • Ergoteles sold 52,546 Orthofix Medical shares in Q1 2023, an estimated $1.08M.
  • Ergoteles first reported a position in Orthofix Medical in Q4 2021 and held it in 4 quarters.
  • Ergoteles's Orthofix Medical position peaked at $1.08M in Q4 2022.
  • 162 funds tracked by Wall St. Rank held Orthofix Medical as of Q1 2023.

Based on Ergoteles's 13F filing for Q1 2023, filed 10 May 2023.